Spots Global Cancer Trial Database for lipiodol
Every month we try and update this database with for lipiodol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation | NCT02631499 | Carcinoma, Hepa... Neoplastic Cell... | TACE Epirubicin lipiodol | 18 Years - 75 Years | Fudan University | |
| Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases | NCT01959061 | Colorectal Canc... | Raltitrexed Oxaliplatin lipiodol | 18 Years - 75 Years | Nanjing Chia-tai Tianqing Pharmaceutical | |
| Pharmacogenetic Study in Hepatocellular Carcinoma Patients. | NCT05291338 | Hepatocellular ... | Doxorubicin Lipiodol | 20 Years - 75 Years | Damanhour University | |
| Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma | NCT01861912 | Carcinoma, Hepa... | Arsenic trioxid... Arsenic trioxid... lipiodol NaCl solution | 18 Years - 75 Years | Guangdong Provincial People's Hospital | |
| Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases | NCT01959061 | Colorectal Canc... | Raltitrexed Oxaliplatin lipiodol | 18 Years - 75 Years | Nanjing Chia-tai Tianqing Pharmaceutical | |
| Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma | NCT02638857 | Recurrence Hepa... Advanced Hepato... | TACE Dendritic Cell lipiodol Mitomycin (MMC) Epirubicin(EADM... Precision Multi... | 18 Years - 65 Years | Second Military Medical University | |
| Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation | NCT02631499 | Carcinoma, Hepa... Neoplastic Cell... | TACE Epirubicin lipiodol | 18 Years - 75 Years | Fudan University | |
| Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma | NCT02755311 | Hepatocellular ... | liver resection transarterial c... carboplatin lipiodol epirubicin , pi... absorbable gela... | 18 Years - 75 Years | Sun Yat-sen University | |
| Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma | NCT02585479 | Hepatocellular ... | Pirarubicin Oxaliplatin Lipiodol Gelfoam | 18 Years - 75 Years | Guangxi Medical University | |
| Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization | NCT02762266 | Child-Pugh Clas... Child-Pugh Clas... Recurrent Hepat... | Stereotactic Bo... Transarterial C... embolic agent lipiodol | 18 Years - | Stanford University | |
| Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC | NCT04459468 | Hepatocellular ... | Lipiodol | 18 Years - 70 Years | University of Texas Southwestern Medical Center | |
| Pharmacogenetic Study in Hepatocellular Carcinoma Patients. | NCT05291338 | Hepatocellular ... | Doxorubicin Lipiodol | 20 Years - 75 Years | Damanhour University | |
| Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma | NCT02638857 | Recurrence Hepa... Advanced Hepato... | TACE Dendritic Cell lipiodol Mitomycin (MMC) Epirubicin(EADM... Precision Multi... | 18 Years - 65 Years | Second Military Medical University | |
| Pharmacogenetic Study in Hepatocellular Carcinoma Patients. | NCT05291338 | Hepatocellular ... | Doxorubicin Lipiodol | 20 Years - 75 Years | Damanhour University | |
| Localization for Deep Lung Nodules: Microcoil Versus Contrast Injection | NCT03617029 | Lung Cancer | Microcoil Lipiodol | 20 Years - 90 Years | National Taiwan University Hospital Hsin-Chu Branch | |
| Localization for Deep Lung Nodules: Microcoil Versus Contrast Injection | NCT03617029 | Lung Cancer | Microcoil Lipiodol | 20 Years - 90 Years | National Taiwan University Hospital Hsin-Chu Branch |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
